drugset / Trial / NCT04985916
ET-01 in Subjects With Lateral Canthal Lines, LCL-210
RandomizedParallel-groupDouble-blindTreatment
Summary
This study tests an investigational drug formulation called ET-01, botulinum toxin, Type A, topical, in lateral canthal lines (LCL).
Timeline
- Start
- 2021-07-19
- Primary completion
- 2024-02-08
- Completion
- 2024-02-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Botulinum toxin type A | Protein / enzyme biologic | — | Topical |